Canadian Urological Association Journal

Skip to main content Skip to main navigation menu Skip to site footer

Current Issue

Vol. 14 No. 2 (2020): CUAJ February

CUAJ is available as a digital "flip."

Published: 2019-07-23

Editorial/Éditorial

Celebrating 75 years of Can-con

D. Robert Siemens

7
- FINAL

CUA News/Actualités AUC

The ABCs of AFCs

Andrew E. MacNeily

8-9
- FINAL
L’ABC des DCC

Andrew E. MacNeily

E46-7
- FINAL

Rapid Communication

Possible drug-induced, vision-threatening maculopathy secondary to chronic pentosan polysulfate sodium (Elmiron®) exposure

R. Christopher Doiron, Mark Bona, J. Curtis Nickel

10-11
- EPUB (DRAFT)
- FINAL

CUA Guideline

Canadian Urological Association-Canadian Urologic Oncology Group guideline on metastatic castration-naive and castration-sensitive prostate cancer

Alan I. So, Kim N. Chi, Brita Danielson, Neil E. Fleshner, Anil Kapoor, Tamim Niazi, Frederic Pouliot, Ricardo A. Rendon, Bobby Shayegan, Srikala Sridhar, Eric Vigneault, Fred Saad

17-23

Original Research

Outcomes and prognosticators of stage 4 renal cell carcinoma with pathological T4 primary lesion using a large, Canadian, multi-institutional database

Justin D. Oake, Premal Patel, Luke T. Lavallée, Jean-Baptiste Lattouf, Olli Saarela, Laurence Klotz, Ronald B. Moore, Anil Kapoor, Antonio Finelli, Ricardo A. Rendon, Jun Kawakami, Alan I. So, Darrel E. Drachenberg

24-30
- EPUB (DRAFT)
- FINAL
The effect of ethnicity on semen analysis and hormones in the infertile patient

Nahid Punjani, Madhur Nayan, Keith Jarvi, Kirk Lo, Susan Lau, Ethan D. Grober

31-5
- EPUB (DRAFT)
- FINAL
Switching from a gonadotropin-releasing hormone (GnRH) agonist to a GnRH antagonist in prostate cancer patients: A systematic review and meta-analysis

Kaleem S. Atchia, Christopher J.D. Wallis, Neil Fleshner, Paul Toren

36-41
- EPUB (DRAFT)
- FINAL
Early experience with chemotherapy intensification for poor-prognosis metastatic germ cell cancer and unfavorable tumor marker decline

Anupam Batra, Scott Ernst, Kylea Potvin, Ricardo Fernandes, Nicholas Power, James Vanhie, Eric Winquist

43-7
- EPUB (DRAFT)
- FINAL

Review

Management algorithms for metastatic prostate cancer

Shawn Malone, Bobby Shayegan, Naveen S. Basappa, Kim Chi, Henry J. Conter, Robert J. Hamilton, Sebastien J. Hotte, Fred Saad, Alan I. So, Laura Park-Wyllie, Huong Hew, Deanna McLeod, Geoffrey Gotto

50-60
- EPUB (DRAFT)
- FINAL
Reprint ‒ Ureteral stent vs. no ureteral stent for ureteroscopy in the management of renal and ureteral calculi: A Cochrane review

Maria Ordonez, Eu Chang Hwang, Michael Borofsky, Caitlin J. Bakker, Shreyas Gandhi, Philipp Dahm

E48-53

Research Letter

Routinely collected data for population-based outcomes research

Blayne Welk

70-2
- EPUB (DRAFT)
- FINAL
Are there differences among bacillus Calmette-Guérin (BCG) strains regarding their clinical efficacy in the treatment of non-muscle-invasive bladder cancer? The jury is still out but the answer is likely no

Guan Hee Tan, Cynthia Kuk, Alexandre R. Zlotta

E54-6
- EPUB (DRAFT)
- FINAL

Commentary

Antagonizing GnRH receptors: A temporary ADT salvage maneuver for prostate cancer patients experiencing PSA failure with GnRH agonist

Jehonathan Pinthus

42
- FINAL
Chemotherapy intensification for first-line treatment of poor-prognosis metastatic germ cell cancer is not yet ready for prime time

Di Maria Jiang, Robert J. Hamilton, Aaron R. Hansen

48-9
- FINAL
Should we routinely place an indwelling ureteral stent post-ureteroscopy?

Sero Andonian

69
- FINAL

Uro-History

The history of endourology in Canada

Darren Beiko, R. John D'A. Honey, Kenneth T. Pace, John D. Denstedt, Hassan Razvi, Denis H. Hosking, Richard W. Norman, James W.L. Wilson

12-6
- EPUB (DRAFT)
- FINAL

View All Issues